Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q419953> ?p ?o }
Showing triples 1 to 62 of
62
with 100 triples per page.
- Q419953 subject Q7469566.
- Q419953 subject Q7486806.
- Q419953 subject Q8579838.
- Q419953 subject Q8808685.
- Q419953 abstract "Topotecan (trade name Hycamtin) is a chemotherapeutic agent that is a topoisomerase inhibitor. It is a synthetic, water-soluble analog of the natural chemical compound camptothecin. It is used in the form of its hydrochloride salt to treat ovarian cancer, lung cancer, and other cancer types.After GlaxoSmithKline received final FDA approval for Hycamtin Capsules on October 15, 2007, topotecan is the first topoisomerase I inhibitor for oral use.".
- Q419953 atcPrefix "L01".
- Q419953 atcSuffix "XX17".
- Q419953 bioavailability "31.4".
- Q419953 casNumber "123948-87-8".
- Q419953 casSupplemental "119413-54-6 (hydrochloride)".
- Q419953 drugbank "DB01030".
- Q419953 fdaUniiCode "7M7YKX2N15".
- Q419953 iupacName "(S)-10-[(dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione monohydrochloride".
- Q419953 pubchem "60700".
- Q419953 thumbnail Topotecan_Structural_Formula_V.1.svg?width=300.
- Q419953 wikiPageExternalLink Abstracts?&vmview=abst_detail_view&confID=26&abstractID=2683.
- Q419953 wikiPageExternalLink drugdictionary.aspx?CdrID=41185.
- Q419953 wikiPageExternalLink topotecanhydrochloride.
- Q419953 wikiPageExternalLink clpt2004533a.html.
- Q419953 wikiPageExternalLink Topotecanchemotherapy.
- Q419953 wikiPageWikiLink Q1138580.
- Q419953 wikiPageWikiLink Q12370.
- Q419953 wikiPageWikiLink Q14599311.
- Q419953 wikiPageWikiLink Q160105.
- Q419953 wikiPageWikiLink Q172341.
- Q419953 wikiPageWikiLink Q281044.
- Q419953 wikiPageWikiLink Q3274739.
- Q419953 wikiPageWikiLink Q419964.
- Q419953 wikiPageWikiLink Q420060.
- Q419953 wikiPageWikiLink Q47912.
- Q419953 wikiPageWikiLink Q485014.
- Q419953 wikiPageWikiLink Q4955921.
- Q419953 wikiPageWikiLink Q535364.
- Q419953 wikiPageWikiLink Q640448.
- Q419953 wikiPageWikiLink Q738170.
- Q419953 wikiPageWikiLink Q7430.
- Q419953 wikiPageWikiLink Q7469566.
- Q419953 wikiPageWikiLink Q7486806.
- Q419953 wikiPageWikiLink Q7860880.
- Q419953 wikiPageWikiLink Q8579838.
- Q419953 wikiPageWikiLink Q8808685.
- Q419953 wikiPageWikiLink Q9368.
- Q419953 wikiPageWikiLink Q9377.
- Q419953 wikiPageWikiLink Q938205.
- Q419953 wikiPageWikiLink Q974135.
- Q419953 atcPrefix "L01".
- Q419953 atcSuffix "XX17".
- Q419953 bioavailability "31.4".
- Q419953 casNumber "123948".
- Q419953 casSupplemental "119413".
- Q419953 drugbank "DB01030".
- Q419953 iupacName "180.0".
- Q419953 pubchem "60700".
- Q419953 unii "7".
- Q419953 type ChemicalSubstance.
- Q419953 type Drug.
- Q419953 type ChemicalObject.
- Q419953 type Thing.
- Q419953 type Q8386.
- Q419953 comment "Topotecan (trade name Hycamtin) is a chemotherapeutic agent that is a topoisomerase inhibitor. It is a synthetic, water-soluble analog of the natural chemical compound camptothecin. It is used in the form of its hydrochloride salt to treat ovarian cancer, lung cancer, and other cancer types.After GlaxoSmithKline received final FDA approval for Hycamtin Capsules on October 15, 2007, topotecan is the first topoisomerase I inhibitor for oral use.".
- Q419953 label "Topotecan".
- Q419953 depiction Topotecan_Structural_Formula_V.1.svg.
